SKYLAR ROBINSON: Open Payments
NPI 1023528270 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 15 payments from 9 companies in 2025. Trend: 2023 $729 · 2024 $984 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $91 |
| Novo Nordisk Inc | 2 | $54 |
| Lilly USA, LLC | 2 | $52 |
| PFIZER INC. | 2 | $37 |
| ABBVIE INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $29 |
| Exact Sciences Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: JARDIANCE, Ozempic, MOUNJARO, ELIQUIS, QULIPTA, Veozah, The Cologuard Plus Collection Kit, BREZTRI.
Industry payments across CT — which companies pay providers there.
